Skip to content

Veradermics

US · MANE #2148 by market cap Listed 2026
119.52 -4.87 -3.92%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Rating change
    Analysts Are Bullish on Top NA Stocks: Veradermics, Incorporated (MANE), Bicara Therapeutics Inc. (BCAX)
    TipRanks · 2026/8/12
  • Rating change
    Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $182
    Market Newswire · 2026/7/16
  • Rating change
    Needham Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $164
    Market Newswire · 2026/8/13
  • Rating change
    B. Riley Analyst Initiates Coverage of Veradermics Stock (MANE) With a Buy Rating
    TipRanks · 2026/7/16
  • Rating change
    Citi Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $160
    Market Newswire · 2026/10/20
  • Citi Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $175
    Market Newswire · 2026/11/10
  • Veradermics(MANE.US) 10% Shareholder Sells US$75.19 Million in Common Stock
    Market Newswire · 2026/11/14
  • Leerink Partners Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $185
    Market Newswire · 2026/11/13
  • Rating change
    Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $138
    Market Newswire · 2026/6/16
  • Rating change
    Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $182
    Market Newswire · 2026/7/7
  • Rating change
    Analysts Conflicted on These NA Names: HeartFlow, Inc. (HTFL), Phoenix Education Partners, Inc. (PXED) and Veradermics, Incorporated (MANE)
    TipRanks · 2026/7/15
  • Citi Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $175
    Market Newswire · 2026/11/10
  • Rating change
    LifeSci Capital Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $170
    Market Newswire · 2026/8/12
  • Rating change
    Leerink Partners Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $150
    Market Newswire · 2026/11/10
  • Form 144 | Veradermics(MANE.US) 10% Stockholder Proposes to Sell 37.6 Million in Common Stocks
    Market Newswire · 2026/11/12
  • Rating change
    LifeSci Capital Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $170
    Market Newswire · 2026/7/15
  • Rating change
    Needham Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $164
    Market Newswire · 2026/7/15
  • Rating change
    Citi Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $160
    Market Newswire · 2026/7/16
  • Rating change
    Citi Maintains Veradermics(MANE.US) With Buy Rating, Maintains Target Price $135
    Market Newswire · 2026/6/22
  • Rating change
    B. Riley Securities Initiates Veradermics(MANE.US) With Buy Rating, Announces Target Price $170
    Market Newswire · 2026/7/15
  • Rating change
    Jefferies Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $138
    Market Newswire · 2026/5/14
  • Rating change
    LifeSci Capital Initiates Veradermics(MANE.US) With Buy Rating, Announces Target Price $135
    Market Newswire · 2026/6/16
  • Rating change
    Citi Maintains Veradermics(MANE.US) With Buy Rating, Raises Target Price to $135
    Market Newswire · 2026/5/18
  • Veradermics(MANE.US) Officer Sells US$7.28 Million in Common Stock
    Market Newswire · 2026/8/19
  • Rating change
    Needham Initiates Veradermics(MANE.US) With Buy Rating, Announces Target Price $136
    Market Newswire · 2026/6/2

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.

Veradermics discussion 0 comments

Add a comment